The total number record retrieved from this search are 12. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_5369	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Murine triple negative breast cancer cell line	4T1	NA	NA	Coomassie brilinat blue staining	4 micromolar	70% cell killing after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5370	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Murine triple negative breast cancer cell line	EMT6	NA	NA	Coomassie brilinat blue staining	4 micromolar	!00% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5371	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Murine triple negative breast cancer cell line	E0771	NA	NA	Coomassie brilinat blue staining	4 micromolar	90% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5372	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Murine triple negative breast cancer cell line	4T1	NA	NA	Coomassie brilinat blue staining	4 micromolar	10% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Impaired IFN beta production by combination	In clinical trial for various cancer cell line	27503504
OV_5373	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Murine triple negative breast cancer cell line	EMT6	NA	NA	Coomassie brilinat blue staining	4 micromolar	30% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Impaired IFN beta production by combination	In clinical trial for various cancer cell line	27503504
OV_5374	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Murine triple negative breast cancer cell line	E0771	NA	NA	Coomassie brilinat blue staining	4 micromolar	20% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Level of IFN beta production does not effected by combination	In clinical trial for various cancer cell line	27503504
OV_5375	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human triple negative breast cancer cell line	Hs578T	NA	NA	Coomassie brilinat blue staining	4 micromolar	100% cell viable after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5376	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human triple negative breast cancer cell line	BT-549	NA	NA	Coomassie brilinat blue staining	4 micromolar	80% cell viable after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5377	Maraba virus	MG1	RNA	Rhabdoviridae	None	Yes	No	No	ATCC	Human triple negative breast cancer cell line	MDA-MB-231	NA	NA	Coomassie brilinat blue staining	4 micromolar	80% cell viable after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	In clinical trial for various cancer cell line	27503504
OV_5378	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Human triple negative breast cancer cell line	Hs578T	NA	NA	Coomassie brilinat blue staining	4 micromolar	20% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Impaired IFN beta production by combination	In clinical trial for various cancer cell line	27503504
OV_5379	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Human triple negative breast cancer cell line	BT-549	NA	NA	Coomassie brilinat blue staining	4 micromolar	20% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Impaired IFN beta production by combination	In clinical trial for various cancer cell line	27503504
OV_5380	Maraba virus	MG1	RNA	Rhabdoviridae	None	No	Virus in combination with 2 micromolar palcitaxel for 48 hours	No	ATCC	Human triple negative breast cancer cell line	MDA-MB-231	NA	NA	Coomassie brilinat blue staining	4 micromolar	30% cell viability after 48 hours	No	No	NA	No response	NA	Induction of apoptosis	Level of IFN beta production does not effected by combination	In clinical trial for various cancer cell line	27503504